{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T08:41:08Z","timestamp":1790066468284,"version":"4.0.1"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T00:00:00Z","timestamp":1720569600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["IZ25-5793-2019-33"],"award-info":[{"award-number":["IZ25-5793-2019-33"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["157660137"],"award-info":[{"award-number":["157660137"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["SFB 894"],"award-info":[{"award-number":["SFB 894"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.jpba.2024.116187","type":"journal-article","created":{"date-parts":[[2024,4,27]],"date-time":"2024-04-27T20:34:59Z","timestamp":1714250099000},"page":"116187","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Metabolism and cytotoxicity studies of the two hallucinogens 1cP-LSD and 4-AcO-DET in human liver and zebrafish larvae models using LC-HRMS\/MS and a high-content screening assay"],"prefix":"10.1016","volume":"245","author":[{"given":"Tanja M.","family":"Gampfer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Sch\u00fctz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Schippers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sari","family":"Rasheed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas","family":"Baumann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lea","family":"Wagmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedikt","family":"Pulver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Folker","family":"Westphal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veit","family":"Flockerzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolf","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus R.","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2024.116187_bib1","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph19084869","article-title":"An update on the implications of new psychoactive substances in public health","volume":"19","author":"Sim\u00e3o","year":"2022","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"10.1016\/j.jpba.2024.116187_bib2","unstructured":"EMCDDA. European Drug Report 2023. Publications of of the European Union, Luxembourg, 2023. https:\/\/www.emcdda.europa.eu\/publications\/european-drug-report\/2023_en. Accessed April 2024."},{"key":"10.1016\/j.jpba.2024.116187_bib3","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1002\/dta.2789","article-title":"Return of the lysergamides. Part VI: analytical and behavioural characterization of 1-cyclopropanoyl-d-lysergic acid diethylamide (1CP-LSD)","volume":"12","author":"Brandt","year":"2020","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.jpba.2024.116187_bib4","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1124\/jpet.122.001454","article-title":"Pharmacologic activity of substituted tryptamines at 5-hydroxytryptamine (5-HT)(2A) Receptor (5-HT(2A)R), 5-HT(2C)R, 5-HT(1A)R, and serotonin transporter","volume":"385","author":"Kozell","year":"2023","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jpba.2024.116187_bib5","doi-asserted-by":"crossref","first-page":"e285","DOI":"10.1093\/jat\/bkac098","article-title":"A fatal case report resulting from the abuse of the designer benzodiazepines clonazolam and flualprazolam in conjunction with dried opium poppy pods","volume":"46","author":"Theofel","year":"2023","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.jpba.2024.116187_bib6","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1002\/dta.295","article-title":"In vitro approaches to studying the metabolism of new psychoactive compounds","volume":"3","author":"Peters","year":"2011","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.jpba.2024.116187_bib7","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1093\/jat\/bkaa010","article-title":"Toxicokinetic studies and analytical toxicology of the new synthetic opioids cyclopentanoyl-fentanyl and tetrahydrofuranoyl-fentanyl","volume":"44","author":"Gampfer","year":"2020","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.jpba.2024.116187_bib8","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.toxlet.2019.01.010","article-title":"Tools for studying the metabolism of new psychoactive substances for toxicological screening purposes - a comparative study using pooled human liver S9, HepaRG cells, and zebrafish larvae","volume":"305","author":"Richter","year":"2019","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.jpba.2024.116187_bib9","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25194474","article-title":"Drug administration routes impact the metabolism of a synthetic cannabinoid in the zebrafish larvae model","volume":"25","author":"Park","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.jpba.2024.116187_bib10","doi-asserted-by":"crossref","first-page":"5551","DOI":"10.1007\/s00216-021-03311-w","article-title":"Recent trends in drugs of abuse metabolism studies for mass spectrometry-based analytical screening procedures","volume":"413","author":"Wagmann","year":"2021","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.jpba.2024.116187_bib11","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1021\/acs.chemrestox.9b00335","article-title":"Use of zebrafish in drug discovery toxicology","volume":"33","author":"Cassar","year":"2020","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.jpba.2024.116187_bib12","article-title":"Zebrafish: An attractive model to study Staphylococcus aureus infection and its use as a drug discovery tool","volume":"14","author":"Rasheed","year":"2021","journal-title":"Pharmaceuticals(Basel)"},{"key":"10.1016\/j.jpba.2024.116187_bib13","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1093\/ilar\/ilw024","article-title":"Opportunities to apply the 3Rs in safety assessment programs","volume":"57","author":"Sewell","year":"2016","journal-title":"Ilar J."},{"key":"10.1016\/j.jpba.2024.116187_bib14","doi-asserted-by":"crossref","DOI":"10.3390\/ph16081158","article-title":"Unraveling the in vitro toxicity profile of psychedelic 2C phenethylamines and their N-benzylphenethylamine (NBOMe) analogues","volume":"16","author":"Martins","year":"2023","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.jpba.2024.116187_bib15","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22136785","article-title":"Human neuronal cell lines as an in vitro toxicological tool for the evaluation of novel psychoactive substances","volume":"22","author":"Sogos","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jpba.2024.116187_bib16","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1021\/acs.chemrestox.6b00403","article-title":"Validation of a multiparametric, high-content-screening assay for predictive\/investigative cytotoxicity: evidence from technology transfer studies and literature review","volume":"30","author":"O'Brien","year":"2017","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.jpba.2024.116187_bib17","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.toxlet.2018.11.007","article-title":"Cytotoxicity of new psychoactive substances and other drugs of abuse studied in human HepG2 cells using an adopted high content screening assay","volume":"301","author":"Richter","year":"2019","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.jpba.2024.116187_bib18","doi-asserted-by":"crossref","first-page":"539","DOI":"10.3389\/fchem.2020.00539","article-title":"How to study the metabolism of new psychoactive substances for the purpose of toxicological screenings-a follow-up study comparing pooled human liver S9, HepaRG cells, and zebrafish larvae","volume":"8","author":"Wagmann","year":"2020","journal-title":"Front Chem."},{"key":"10.1016\/j.jpba.2024.116187_bib19","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.reprotox.2011.06.121","article-title":"Zebrafish embryos as an alternative to animal experiments--a commentary on the definition of the onset of protected life stages in animal welfare regulations","volume":"33","author":"Str\u00e4hle","year":"2012","journal-title":"Reprod. Toxicol."},{"key":"10.1016\/j.jpba.2024.116187_bib20","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1007\/s00204-020-02726-1","article-title":"Toxicokinetics and toxicodynamics of the fentanyl homologs cyclopropanoyl-1-benzyl-4 -fluoro-4-anilinopiperidine and furanoyl-1-benzyl-4-anilinopiperidine","volume":"94","author":"Gampfer","year":"2020","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.jpba.2024.116187_bib21","doi-asserted-by":"crossref","first-page":"3539","DOI":"10.1007\/s00204-021-03148-3","article-title":"Cytotoxicity, metabolism, and isozyme mapping of the synthetic cannabinoids JWH-200, A-796260, and 5F-EMB-PINACA studied by means of in vitro systems","volume":"95","author":"Gampfer","year":"2021","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.jpba.2024.116187_bib22","doi-asserted-by":"crossref","DOI":"10.3390\/metabo11080509","article-title":"In vitro metabolic fate of the synthetic cannabinoid receptor agonists QMPSB and QMPCB (SGT-11) including isozyme mapping and esterase activity","volume":"11","author":"Richter","year":"2021","journal-title":"Metabolites"},{"key":"10.1016\/j.jpba.2024.116187_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.tox.2022.153258","article-title":"A simplified strategy to assess the cytotoxicity of new psychoactive substances in HepG2 cells using a high content screening assay - Exemplified for nine compounds","volume":"476","author":"Gampfer","year":"2022","journal-title":"Toxicology"},{"key":"10.1016\/j.jpba.2024.116187_bib24","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.toxlet.2014.08.004","article-title":"Development of an in vitro cytochrome P450 cocktail inhibition assay for assessing the inhibition risk of drugs of abuse","volume":"230","author":"Dinger","year":"2014","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.jpba.2024.116187_bib25","doi-asserted-by":"crossref","first-page":"4751","DOI":"10.1007\/s00216-018-1558-9","article-title":"In vitro metabolic fate of nine LSD-based new psychoactive substances and their analytical detectability in different urinary screening procedures","volume":"411","author":"Wagmann","year":"2019","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.jpba.2024.116187_bib26","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1111\/j.1742-4658.2011.08133.x","article-title":"Metabolism of N-methyl-amide by cytochrome P450s: formation and characterization of highly stable carbinol-amide intermediate","volume":"278","author":"Perrin","year":"2011","journal-title":"Febs J."},{"key":"10.1016\/j.jpba.2024.116187_bib27","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1007\/s00414-011-0652-8","article-title":"A validated method for quantitation of psilocin in plasma by LC-MS\/MS and study of stability","volume":"126","author":"Martin","year":"2012","journal-title":"Int. J. Leg. Med."},{"key":"10.1016\/j.jpba.2024.116187_bib28","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1007\/s40262-017-0513-9","article-title":"Pharmacokinetics and pharmacodynamics of lysergic acid diethylamide in healthy subjects","volume":"56","author":"Dolder","year":"2017","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.jpba.2024.116187_bib29","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.cbpc.2018.06.005","article-title":"Zebrafish (Danio rerio): a valuable tool for predicting the metabolism of xenobiotics in humans?","volume":"212","author":"de Souza Anselmo","year":"2018","journal-title":"Comp. Biochem. Physiol. C. Toxicol. Pharmacol."},{"key":"10.1016\/j.jpba.2024.116187_bib30","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.aquatox.2005.07.005","article-title":"Cholin- and carboxylesterase activities in developing zebrafish embryos (Danio rerio) and their potential use for insecticide hazard assessment","volume":"75","author":"K\u00fcster","year":"2005","journal-title":"Aquat. Toxicol."},{"key":"10.1016\/j.jpba.2024.116187_bib31","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.forsciint.2018.01.006","article-title":"Is LSD toxic?","volume":"284","author":"Nichols","year":"2018","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.jpba.2024.116187_bib32","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.toxlet.2019.10.022","article-title":"Cardiotoxic effects of [3-[2-(diethylamino)ethyl]-1H-indol-4-yl] acetate and 3-[2-[ethyl(methyl)amino]ethyl]-1H-indol-4-ol","volume":"319","author":"Yoon","year":"2020","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.jpba.2024.116187_bib33","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1124\/dmd.109.031831","article-title":"A comparison of whole genome gene expression profiles of HepaRG cells and HepG2 cells to primary human hepatocytes and human liver tissues","volume":"38","author":"Hart","year":"2010","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.jpba.2024.116187_bib34","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/clpt.2013.78","article-title":"Intracellular drug concentrations and transporters: measurement, modeling, and implications for the liver","volume":"94","author":"Chu","year":"2013","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.jpba.2024.116187_bib35","article-title":"Can the intake of a synthetic tryptamine be detected only by blood plasma analysis? A clinical toxicology case involving 4-HO-MET","author":"Wagmann","year":"2021","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.jpba.2024.116187_bib36","article-title":"Study of the in vitro and in vivo metabolism of the tryptamine 5-MeO-MiPT using human liver microsomes and real case samples","author":"Grafinger","year":"2017","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.jpba.2024.116187_bib37","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s13318-023-00822-y","article-title":"Pharmacokinetics of N,N-dimethyltryptamine in Humans","volume":"48","author":"Good","year":"2023","journal-title":"Eur. J. Drug Metab. Pharmacokinet."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708524002279?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708524002279?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T22:46:57Z","timestamp":1778539617000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708524002279"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":37,"alternative-id":["S0731708524002279"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2024.116187","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabolism and cytotoxicity studies of the two hallucinogens 1cP-LSD and 4-AcO-DET in human liver and zebrafish larvae models using LC-HRMS\/MS and a high-content screening assay","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2024.116187","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"116187"}}